Science commentary: rational drug design for Alzheimer's disease
- PMID: 10215361
Science commentary: rational drug design for Alzheimer's disease
Comment in
-
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.BMJ. 1999 Mar 6;318(7184):633-8. doi: 10.1136/bmj.318.7184.633. BMJ. 1999. PMID: 10066203 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical